ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.755
      -0.04%
      Bitcoin
      65,111.79
      -0.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Context Therapeutics Inc (CNTX)

      7. Context Therapeutics Inc (CNTX) News

      CNTX

      Context Therapeutics (CNTX)

      Context Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CNTX
      DateTimeSourceHeadlineSymbolCompany
      05/11/20224:01PMGlobeNewswire Inc.Context Therapeutics® Reports First Quarter 2022 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
      05/09/20225:12PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNTXContext Therapeutics Inc
      05/05/20227:30AMGlobeNewswire Inc.Context Therapeutics® Announces Poster Presentation at the Upcoming 2022 ASCO Annual MeetingNASDAQ:CNTXContext Therapeutics Inc
      04/14/20226:17AMTipRanksH.C. Wainwright Thinks Context Therapeutics’ Stock is Going to RecoverNASDAQ:CNTXContext Therapeutics Inc
      04/11/20227:30AMGlobeNewswire Inc.Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022NASDAQ:CNTXContext Therapeutics Inc
      04/06/20227:30AMGlobeNewswire Inc.Context Therapeutics® to Participate in Two April 2022 Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
      04/04/20225:10PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CNTXContext Therapeutics Inc
      04/04/20224:14PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNTXContext Therapeutics Inc
      03/24/20226:16AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Context Therapeutics (CNTX)NASDAQ:CNTXContext Therapeutics Inc
      03/23/20224:27PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNTXContext Therapeutics Inc
      03/23/20224:23PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNTXContext Therapeutics Inc
      03/23/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTXContext Therapeutics Inc
      03/23/20224:01PMGlobeNewswire Inc.Context Therapeutics® Reports Full Year 2021 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
      03/08/20226:12PMGlobeNewswire Inc.Context Therapeutics® Announces Acceptance of Five Abstracts to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022NASDAQ:CNTXContext Therapeutics Inc
      02/25/20224:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
      02/25/20224:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
      02/22/20227:30AMGlobeNewswire Inc.Context Therapeutics® to Participate in the Sachs 15th Annual European Life Sciences CEO ForumNASDAQ:CNTXContext Therapeutics Inc
      02/17/20224:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
      02/17/20224:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
      01/11/20228:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CNTXContext Therapeutics Inc
      01/10/20228:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTXContext Therapeutics Inc
      01/05/20224:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNTXContext Therapeutics Inc
      01/05/20224:01PMGlobeNewswire Inc.Context Therapeutics® Strengthens Research & Development TeamNASDAQ:CNTXContext Therapeutics Inc
      01/05/20226:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTXContext Therapeutics Inc
      01/04/20227:30AMGlobeNewswire Inc.Context Therapeutics® to Participate in Two January 2022 Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
      12/20/20214:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNTXContext Therapeutics Inc
      12/17/20214:19PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTXContext Therapeutics Inc
      12/17/20214:13PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CNTXContext Therapeutics Inc
      12/17/20214:09PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CNTXContext Therapeutics Inc
      12/17/20218:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CNTXContext Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:CNTX